| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| p-Ethynylphenylalanine |
4-乙炔基-L-苯丙氨酸 HCL |
278605-15-5 |
詳細(xì)
|
| 2',3'-cGAMP；2'-3'-cyclic GMP-AMP |
2,3-CGAMP |
1441190-66-4 |
詳細(xì)
|
| A2B receptor antagonist 1 |
531506-36-2 |
531506-36-2 |
詳細(xì)
|
| Anti-inflammatory agent 1 |
1096621-42-9 |
1096621-42-9 |
詳細(xì)
|
| Thrombin inhibitor 1 |
855998-46-8 |
855998-46-8 |
詳細(xì)
|
| 3-Deazaadenosine hydrochloride |
3-DEAZAADENOSINE HYDROCHLORIDE |
86583-19-9 |
詳細(xì)
|
| (1S,2S,3R)-DT-061 |
(1S,2S,3R)-DT-061 |
1809427-20-0 |
詳細(xì)
|
| (2S,3S)-E1R |
(2S,3S)-E1R |
1424832-57-4 |
詳細(xì)
|
| 2',5'-Dideoxyadenosine |
2',5'-DIDEOXYADENOSINE |
6698-26-6 |
詳細(xì)
|
| 2'-Deoxypseudoisocytidine |
2'-DEOXYPSEUDOISOCYTIDINE |
65358-18-1 |
詳細(xì)
|
| 2-Methyl-5-HT hydrochloride；2-Methyl-5-hydroxytryptamine hydrochloride |
2-METHYL-5-HT HYDROCHLORIDE |
845861-49-6 |
詳細(xì)
|
| Cephalexin |
頭孢氨芐 |
15686-71-2 |
詳細(xì)
|
| (1S,2S)-Bortezomib |
硼替佐米雜質(zhì)E |
1132709-14-8 |
詳細(xì)
|
| (3S,5R)-Pitavastatin calcium |
(3S, 5R)-匹伐他汀鈣 |
254452-88-5 |
詳細(xì)
|
| 4-Desmethyl Istradefylline |
伊曲茶堿雜質(zhì) |
160434-48-0 |
詳細(xì)
|
| AMPK activator 1 |
1152423-98-7 |
1152423-98-7 |
詳細(xì)
|
| PSN-GK1 |
化合物 PSN-GK1 |
745051-61-0 |
詳細(xì)
|
| 2'-Azido-2'-deoxyuridine；N3dUrd |
2'-疊氮-2'-脫氧尿苷 |
26929-65-7 |
詳細(xì)
|
| 2-Keto-D-Glucose；D-Glucosone |
D-葡糖醛酮 |
1854-25-7 |
詳細(xì)
|
| E1R |
E1R |
1301211-78-8 |
詳細(xì)
|
| Desethyl KBT-3022 |
101001-72-3 |
101001-72-3 |
詳細(xì)
|
| Nanofin |
2,6-二甲基哌啶 |
504-03-0 |
詳細(xì)
|
| LDL-IN-3 |
2,6-Bis(1,1-dimethylethyl)-4-[[(4-methoxyphenyl)dimethylsilyl]methoxy]phenol |
180908-67-2 |
詳細(xì)
|
| QF0301B |
149247-12-1 |
149247-12-1 |
詳細(xì)
|
| Anti-neurodegeneration agent 1 |
289893-23-8 |
289893-23-8 |
詳細(xì)
|
| 20(S)-Hydroxycholesterol |
20Α-羥基膽固醇 |
516-72-3 |
詳細(xì)
|
| 3,4-Dihydroxybenzylamine hydrobromide |
3,4-二羥基芐胺·氫溴酸 |
16290-26-9 |
詳細(xì)
|
| 2-Methylcitric acid trisodium；Methylcitric acid trisodium |
TRISODIUM 2-METHYLCITRATE, RACEMIC MIXTURE OF DIASTEREOMERS |
117041-96-0 |
詳細(xì)
|
| DT-061 |
SMAP |
1809427-19-7 |
詳細(xì)
|
| 3-Nitrocoumarin |
2H-1-Benzopyran-2-one, 3-nitro- |
28448-04-6 |
詳細(xì)
|
| 3-CPs |
ethyl 7-oxo-7H-furo[3,2-g][1]benzopyran-6-carboxylate |
20073-24-9 |
詳細(xì)
|
| 4-Hydroxyacetophenone oxime |
4-羥基苯乙酮肟 |
34523-34-7 |
詳細(xì)
|
| 2-Hydroxy Ibuprofen；(±)-2-Hydroxy Ibuprofen |
2-羥基布洛芬 |
51146-55-5 |
詳細(xì)
|
| 3-arylisoquinolinamine derivative |
1029008-71-6 |
1029008-71-6 |
詳細(xì)
|
| 24R-Calcipotriol；PRI 2202 |
24R-卡泊三醇 |
112827-99-3 |
詳細(xì)
|
| 3'-Azido-3'-deoxy-5-methylcytidine |
3'-AZIDO-3'-DEOXY-5-METHYLCYTIDINE |
1282040-14-5 |
詳細(xì)
|
| Neuromuscular Disorder-Targeting Compound 1 |
374538-23-5 |
374538-23-5 |
詳細(xì)
|
| PGS-IN-1 |
102271-49-8 |
102271-49-8 |
詳細(xì)
|
| DPP-IV-IN-1 |
625110-37-4 |
625110-37-4 |
詳細(xì)
|
| Antiulcer Agent 1 |
3-[[2-[[2-(3,4-Dimethoxyphenyl)ethyl]amino]-2-oxoethyl]amino]benzamide |
76001-09-7 |
詳細(xì)
|
| Acebutolol hydrochloride |
鹽酸醋丁洛爾 |
34381-68-5 |
詳細(xì)
|
| 3-Hydroxy-4-methoxyacetophenone |
4-甲氧基-3-羥基苯乙酮 |
6100-74-9 |
詳細(xì)
|
| 2'-Ethyl Simvastatin |
辛伐他汀雜質(zhì)I |
79902-42-4 |
詳細(xì)
|
| 3-O-Methyltolcapone；Ro 40-7591 |
1-(4-羥基-3-甲氧基-5-硝基苯基)-3-(4-甲基苯基)丙-2-酮 |
134612-80-9 |
詳細(xì)
|
| 24-Norursodeoxycholic acid |
熊去氧膽酸雜質(zhì)24 |
99697-24-2 |
詳細(xì)
|
| 3-Oxo Atorvastatin |
阿托伐他汀3-氧雜質(zhì) |
887196-30-7 |
詳細(xì)
|
| (3S,5S)-Pitavastatin calcium |
(3S, 5S)-匹伐他汀鈣鹽 |
254452-92-1 |
詳細(xì)
|
| 2-Methylcitric acid；Methylcitric acid |
2-甲基檸檬酸 |
6061-96-7 |
詳細(xì)
|
| 3-Hydroxy agomelatine D3 |
3-Hydroxy Agomelatine D3 |
1079774-23-4 |
詳細(xì)
|
| MAO-IN-1 |
124991-40-8 |
124991-40-8 |
詳細(xì)
|
| 3α-Hydroxymogrol |
3Α-羥基羅漢果醇 |
1343402-73-2 |
詳細(xì)
|
| (-)-GSK598809；1S,5R-GSK598809 |
(-)-GSK598809 |
863680-46-0 |
詳細(xì)
|
| (2R,3S)-E1R |
(2R,3S)-E1R |
1424832-60-9 |
詳細(xì)
|
| Itraconazole |
伊曲康唑 |
84625-61-6 |
詳細(xì)
|
| 2-Methyl-5-HT maleate；2-Methylserotonin maleate;2-Methyl-5-hydroxytryptamine maleate;2-Me-HT maleate |
2-METHYLSEROTONIN MALEATE SALT |
78263-91-9 |
詳細(xì)
|
| 4,7,10,13,16-Docosapentaenoic acid |
4,7,10,13,16-DOCOSAPENTAENOIC ACID |
2313-14-6 |
詳細(xì)
|
| 4-Diethylaminobenzaldehyde |
N,N-二乙基-4-氨基苯甲醛 |
120-21-8 |
詳細(xì)
|
| (3S,5R)-Rosuvastatin |
(3S,5R)-瑞舒伐他汀 |
1242184-42-4 |
詳細(xì)
|
| LH secretion antagonist 1 |
2,6-Methano-3-benzazocine-6,8(1H)-diol, 3-(3-butyn-1-yl)-2,3,4,5-tetrahydro-11,11-dimethyl-, hydrochloride |
88531-67-3 |
詳細(xì)
|
| Calcium channel-modulator-1 |
136941-70-3 |
136941-70-3 |
詳細(xì)
|
| 2',5-Difluoro-2'-deoxycytidine |
2',5-DIFLUORO-2'-DEOXYCYTIDINE |
581772-30-7 |
詳細(xì)
|
| Estrone |
雌酚酮 |
53-16-7 |
詳細(xì)
|
| (2R,4R)-APDC |
(2R,4R)-APDC |
169209-63-6 |
詳細(xì)
|
| (3S,5R)-Fluvastatin D6 sodium；(3S,5R)-XU 62-320 D6 |
|
2249799-35-5 |
詳細(xì)
|
| 3'-O-Acetylhamaudol |
3-O-乙?；ッ┓?/td>
| 30358-88-4 |
詳細(xì)
|
| 3-Bromocytisine |
3-Bromocytisine |
207390-14-5 |
詳細(xì)
|
| VEGFR-2-IN-9；KDR-in-4 |
化合物 T10123 |
408502-06-7 |
詳細(xì)
|
| (2S,3R)-Voruciclib |
2-[2-chloro-4-(trifluoromethyl)phenyl]-5,7-dihydroxy-8-[(2R,3S)-2-(hydroxymethyl)-1-methylpyrrolidin-3-yl]chromen-4-one |
1253731-24-6 |
詳細(xì)
|
| Propantheline bromide |
溴丙胺太林 |
50-34-0 |
詳細(xì)
|
| CRTh2 antagonist 1 |
CRTH2 ANTAGONIST 1 |
1379445-54-1 |
詳細(xì)
|
| 3-O-Acetylbufotalin |
3-乙酰蟾毒它靈 |
4029-69-0 |
詳細(xì)
|
| 4'-Ethynyl-2'-deoxyadenosine |
4'-ETHYNYL-2'-DEOXYADENOSINE |
306305-07-7 |
詳細(xì)
|
| Amoxicillin trihydrate |
阿莫西林三水物 |
61336-70-7 |
詳細(xì)
|
| 3,3'-Diiodo-L-thyronine；3,3'-T2 |
3,3'-二碘甲腺原氨酸 |
4604-41-5 |
詳細(xì)
|
| 2-O-β-D-Glucopyranosyl-L-ascorbic acid；AA-2βG |
枸杞酸 |
562043-82-7 |
詳細(xì)
|
| 24-Hydroxycholesterol |
24-HYDROXYCHOLESTEROL |
30271-38-6 |
詳細(xì)
|
| 2614W94 |
205187-35-5 |
205187-35-5 |
詳細(xì)
|
| Itch-Targeting Compound 1 |
793674-76-7 |
793674-76-7 |
詳細(xì)
|
| PF-592379 |
710655-15-5 |
710655-15-5 |
詳細(xì)
|
| 3-Carene |
3-蒈烯 |
13466-78-9 |
詳細(xì)
|
| 2-Methyl-5-HT；2-Methyl-5-hydroxytryptamine |
2-甲基-5-羥基色氨酸鹽酸 |
78263-90-8 |
詳細(xì)
|
| Verapamil hydrochloride |
鹽酸維拉帕米 |
152-11-4 |
詳細(xì)
|
| Amikacin |
阿米卡星 |
37517-28-5 |
詳細(xì)
|
| 3-Bromo-7-nitroindazole |
3-溴-7-鈮溴呋喃酯 |
74209-34-0 |
詳細(xì)
|
| (3S,5R)-Fluvastatin sodium；(3S,5R)-XU 62-320 |
(3S,5R)氟伐他汀鈉鹽 |
94061-81-1 |
詳細(xì)
|
| 3-Hydroxy agomelatine |
阿戈美拉汀雜質(zhì) |
166526-99-4 |
詳細(xì)
|
| 2-Iodomelatonin |
N-[2-(2-碘-5-甲氧基吲哚-3-基)乙基]乙酰胺 |
93515-00-5 |
詳細(xì)
|
| 4-Acetylsimvastatin |
辛伐他汀雜質(zhì)B(乙?；练ニ? |
145576-25-6 |
詳細(xì)
|
| (2R,3R)-E1R |
(2R,3R)-E1R |
1400888-63-2 |
詳細(xì)
|
| 4-Hydroxyatomoxetine D3 |
4-羥基托莫西汀-D3 |
1217686-14-0 |
詳細(xì)
|
| 3-Deazaadenosine |
3-脫氮腺苷 |
6736-58-9 |
詳細(xì)
|
| 4-Acetamidophenyl acetate |
4-乙酰氧基乙酰苯胺 |
2623-33-8 |
詳細(xì)
|
| 264W94 |
264W 94 |
178961-24-5 |
詳細(xì)
|
| (3R,5S)-Atorvastatin sodium |
阿托伐他汀(3R,5S)-異構(gòu)體鈉 |
131275-93-9 |
詳細(xì)
|
| (3R,5R)-Rosuvastatin |
(3R,5R)-羅伐他汀 |
1094100-06-7 |
詳細(xì)
|
| 4-Desmethoxy Omeprazole |
埃索美拉唑雜質(zhì)B |
110374-16-8 |
詳細(xì)
|
| Substance P Receptor Antagonist 1 |
225526-17-0 |
225526-17-0 |
詳細(xì)
|
| 4-Bromo A23187；4-?Bromo A23187 |
4-溴代-鈣離子載體 |
76455-48-6 |
詳細(xì)
|
| 4-Hydroxyatomoxetine |
4'-羥基托莫西汀 |
435293-66-6 |
詳細(xì)
|
| (3R,4R)-A2-32-01 |
(3R,4R)-A2-32-01 |
1359752-95-6 |
詳細(xì)
|